Tradestie Institutional Equity Comparison Engine

MTNB vs ABBV โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-19 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ABBV Overall Edge

ABBV Captures Institutional Edge (4โ€“0 Pillars ยท 9โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Abbvie Inc. (ABBV) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, MTNB trades at N/M Forward P/E with 0.0% operating margin (-100.0% YoY revenue) versus ABBV at 17.4x Forward P/E and 36.6% operating margin (+10.3% YoY). In options structure, MTNB sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against ABBV sits in CONSOLIDATION (12th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner ABBV
MTNB N/M vs ABBV 17.4x Fwd P/E
Growth & Margin Winner ABBV
Op Margin 0.0% vs 36.6% ยท YoY -100.0% vs +10.3%
Momentum & Technical Winner ABBV
1Y -31.4% vs +21.2% ยท 52W Pos 22% vs 83%
Options & Structure Winner ABBV
UNCLASSIFIED (N/A IV) vs CONSOLIDATION (12th %ile IV)
MTNB NYSE American
Matinas BioPharma Holdings, Inc.
Pharmaceutical Preparations
$0.81
-10.98% 1D
Market Cap $979,904
1M Return -46.7%
1Y Return -31.35%
Forward P/E N/M
Unified AI Score
54.6 / 100 HOLD
Tech 53.0 Fund 58.0 Flow 50.0 Mom 60.0
ABBV NYSE
Abbvie Inc.
Pharmaceutical Preparations
$283.54
-0.86% 1D
Market Cap $505.6B
1M Return -0.44%
1Y Return +21.24%
Forward P/E 17.4x
Unified AI Score
53.5 / 100 HOLD
Tech 42.0 Fund 46.0 Flow 72.0 Mom 21.1

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: MTNB -31.35% ABBV +21.24% Spread: +52.59 pp (ABBV Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period MTNB Revenue ABBV Revenue MTNB Op. Margin ABBV Op. Margin Margin Edge
FY2018 $0M $32.8B -12230.9% 19.5% ABBV
FY2019 $0M $33.3B -21067.4% 39.0% ABBV
FY2020 $0M $45.8B -15288.4% 24.8% ABBV
FY2021 $0M $56.2B -74954.5% 31.9% ABBV
FY2022 $0M $58.0B -771.3% 31.2% ABBV
FY2023 $0M $54.3B -2168.4% 23.5% ABBV
FY2024 N/A $56.3B N/A 16.2% ABBV
FY2025 N/A $61.2B N/A 24.6% ABBV

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: MTNB (1) vs ABBV (9)
Institutional Metric MTNB ABBV Criterion Row Winner
Market Capitalization Scale $979,904 $505.6B Larger Scale ABBV
Trailing P/E Ratio Valuation N/M 49.1x Lower Multiple ABBV
Forward P/E Ratio Valuation N/M 17.4x Lower Multiple ABBV
Revenue Growth (YoY) Growth -100.0% +10.3% Higher Growth ABBV
Operating Margin (TTM) Profitability 0.0% 36.6% Higher Margin ABBV
Net Profit Margin Profitability 0.0% 15.7% Higher Margin ABBV
Return on Equity (ROE) Capital Efficiency -147.5% 62.3% Higher ROE ABBV
52-Week Range Position Momentum 22% ($0โ€“$3) 83% ($191โ€“$303) Stronger Trend ABBV
Beta / 30D Volatility Risk Regime -7.20ฮฒ ยท 147% Vol -0.02ฮฒ ยท 20% Vol Lower Realized Risk ABBV
Unified Institutional Score Composite Signal 54.6 / 100 (HOLD) 53.5 / 100 (HOLD) Higher Composite MTNB

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full MTNB vs ABBV Buy Guide
MTNB UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live MTNB Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ABBV CONSOLIDATION
98d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 12th %ile
IV Regime Compressed (<25th %ile)
Live ABBV Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither MTNB nor ABBV registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.